Status:
RECRUITING
Influence of Hypoxic, Normobaric and Hypobaric Training on the Immunometabolism of Post-covid-19 Athletes
Lead Sponsor:
Faculdade de Motricidade Humana
Collaborating Sponsors:
University of Sao Paulo
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Conditions:
Normobaric Hypoxia
Hypoventilation
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
COVID-19 has significantly impacted sports globally, with event postponements, training disruptions, and wide-ranging concerns. SARS-CoV-2 infection can result in hyperinflammation and cardiopulmonary...
Detailed Description
Covid-19, caused by SARS-CoV-2, can progress to pulmonary hyperinflammation and cardiopulmonary changes, with hypoxia being one of the main signs of worsening. In hypoxia, there is activation of HIF-1...
Eligibility Criteria
Inclusion
- more than 5 years of training experience in an resistance modality;
- participates in national or international championships regularly;
- athletes convalescing from covid-19, at least 30 days after diagnosis and/or hospital discharge;
- manifested mild to severe symptoms;
- vaccinated or not against SARS-CoV-2;
- antigen self-test for SARS-CoV-2 negative.
Exclusion
- athletes who have had an acclimatization experience or exposure to altitude lasting more than 10 days in the last 6 months;
- contain signs or symptoms of acute covid-19;
- present a positive SARS-CoV-2 antigen self-test;
- pregnant or postpartum women;
- use anti-inflammatory or immunosuppressive medications.
Key Trial Info
Start Date :
January 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06128941
Start Date
January 3 2024
End Date
June 1 2024
Last Update
February 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Human Kinetics
Lisbon, Portugal, 1495-002 Cruz-Quebrada